I
183.14
3.43 (1.91%)
| Penutupan Terdahulu | 179.71 |
| Buka | 179.88 |
| Jumlah Dagangan | 912,764 |
| Purata Dagangan (3B) | 1,023,555 |
| Modal Pasaran | 14,243,187,712 |
| Harga / Pendapatan (P/E TTM) | 24.22 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.53 |
| Harga / Jualan (P/S) | 1.84 |
| Harga / Buku (P/B) | 1.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Oct 2025 |
| Margin Keuntungan | 9.82% |
| Margin Operasi (TTM) | 12.83% |
| EPS Cair (TTM) | 9.71 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -4.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 24.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 37.12% |
| Nisbah Semasa (MRQ) | 1.29 |
| Aliran Tunai Operasi (OCF TTM) | 1.16 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 901.28 M |
| Pulangan Atas Aset (ROA TTM) | 4.35% |
| Pulangan Atas Ekuiti (ROE TTM) | 8.30% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Menaik | Bercampur |
| Diagnostics & Research (Global) | Menaik | Bercampur | |
| Stok | ICON plc | Menurun | Menurun |
AISkor Stockmoo
-0.6
| Konsensus Penganalisis | -3.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.63 |
|
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.63% |
| % Dimiliki oleh Institusi | 92.70% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 185.00 (Barclays, 1.02%) | Pegang |
| Median | 175.00 (-4.45%) | |
| Rendah | 172.00 (TD Cowen, -6.08%) | Pegang |
| Purata | 176.75 (-3.49%) | |
| Jumlah | 4 Pegang | |
| Harga Purata @ Panggilan | 172.15 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BMO Capital | 13 Nov 2025 | 175.00 (-4.44%) | Pegang | 163.45 |
| Barclays | 24 Oct 2025 | 185.00 (1.02%) | Pegang | 178.11 |
| 02 Oct 2025 | 190.00 (3.75%) | Pegang | 192.96 | |
| TD Cowen | 24 Oct 2025 | 172.00 (-6.08%) | Pegang | 178.11 |
| Jefferies | 09 Sep 2025 | 175.00 (-4.44%) | Pegang | 168.94 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 02 Dec 2025 | Pengumuman | ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions |
| 12 Nov 2025 | Pengumuman | ICON plc to Present at the Jefferies London Healthcare Conference |
| 22 Oct 2025 | Pengumuman | ICON Reports Third Quarter 2025 Results |
| 24 Sep 2025 | Pengumuman | ICON plc Schedules Third Quarter 2025 Earnings Conference Call |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |